Abstract:The optimal treatment of intramural hematoma (IMH) involving the ascending aorta remains controversial. This study aimed to analyze the results of the management of patients with acute IMH involving the ascending aorta and extending into the descending thoracic aorta, to compare outcomes of descending thoracic endovascular aortic repair (TEVAR) with that of medical therapy (MT), and to assess the risk factors associated with adverse aortic events.We retrospectively analyzed all patients diagnosed with acute IMH involving the ascending aorta and extending into the descending thoracic aorta from January 2012 to December 2019. The primary end-points during follow-up were aortic disease-related death and adverse aorta-related events that required surgical or endovascular treatment, such as aortic rupture, the progression of aortic disease, or endoleak.We identified a total of 135 patients with acute IMH involving the ascending aorta and extending into the descending thoracic aorta, of whom 104 underwent descending TEVAR (group 1) and 31 were managed with MT (group 2). Freedom from adverse aorta-related events at 1, 3, and 5 years was significantly higher for patients who underwent descending TEVAR compared with those managed with medical therapy (89.2%, 88.2%, and 84.0% vs 74.2%, 74.2%, and 74.2% [P=0.026], respectively). The 1-, 3- and 5-year survival rates for patients in the descending TEVAR group was 100%, 100%, 100%, respectively, which was significantly higher than the survival of the MT group: 93.5%, 93.5%, and 81.9%, respectively (P=0.002). On a univariate analysis among patients receiving medical treatment, those who suffered adverse aorta-related events showed a higher prevalence of renal insufficiency (55.6% versus 9.1%; P=0.003). In medically treated patients, multivariate analysis showed that renal insufficiency was the only independent risk factor associated with adverse aorta-related events (HR = 8.691; 95% confidence interval [CI], 2.056-36.737; P = 0.003).Based on our study, compared to medical therapy, descending TEVAR might be the more favorable treatment for patients with IMH involving the ascending aorta and extending into the descending thoracic aorta. Patients with renal insufficiency are more likely to experience adverse aorta-related events, which implies the need for subsequent intervention or an increased risk of mortality. The risk factor would be helpful for clinical decision making.

Treatment of acute type B intramural hematoma of the aorta

Acute Type B Aortic Intramural Hematoma: Treatment Strategy And The Role Of Endovascular Repair

Early Aggressive Medical Treatment Associated with Selective Prophylactic Aortic Stent-Grafting for Aortic Intramural Hematoma

Endoluminal and Surgical Treatment for the Management of Stanford Type A Aortic Dissection.

Deployment of Endograft in the Ascending Aorta to Reverse Type A Aortic Dissection.

Minimally Invasive Approaches for Treating Disorders of the Great Vessels

Clinical characteristics and prognostic value of focal enhancement on computed tomography angiography in patients with acute type B aortic intramural hematoma

Endovascular Repair of Type B Aortic Dissection: a Report of 46 Patients

Endovascular Stent-Grafts Treatment in Acute Aortic Dissection (type B): Clinical Outcomes During Early, Late, or Chronic Phases

Outcomes of intramural hematoma involving the ascending aorta and extending into the descending thoracic aorta

Endovascular Therapy for Stanford Type B Aortic Dissections: a Report of 158 Cases

The treatment choice and outcome of aortic intramural hematoma

Endovascular Repair For Retrograde Type A Intramural Hematoma With Focal Intimal Disruption In Descending Aorta

Review and mid-term follow-up of Stanford type B aortic dissections treated by endovascular placement of stent-grafts

Observation on curative effect of endovascular repair of type B aortic dissection

Survival and aortic remodeling outcomes in patients with type B aortic intramural hematoma in the endovascular era: an observational cohort study

Endovascular Stent-Graftsfor Acute Stanford Type B Aortic Dissection

Endovascular Technique for Stanford B Type Aortic Dissection

Endovascular Treatment of Arch and Proximal Thoracic Aortic Lesions

A single-center experience of type B aortic intramural hematoma

Endovascular therapy for stanford type B aortic dissection in 102 cases.